aluates Reports

$ 0.0

Automative

Global Solid Tumor Drug Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-19N6828

Global Solid Tumor Drug Market Insights and Forecast to 2028

BUY CHAPTERS

Global Solid Tumor Drug Market Research Report 2025

Code: QYRE-Auto-19N6828

Report

September 2025

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Astrazeneca plc

Biogen

Baxter

Celgene Corporation

Abbott Laboratories

Pfizer Inc

Amgen Limited& Amgen Ireland Limited

Bristol Myers Squibb Company

GlaxoSmithKline PLC

F Hoffmann La Roche Ltd

Eli Lilly and Company

Johnson & Johnson

Amgen Limited& Amgen Ireland Limited

Johnson & Johnson

Solid Tumor Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Solid Tumor Drug Market

The global market for Solid Tumor Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Solid Tumor Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solid Tumor Drug.

The Solid Tumor Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Solid Tumor Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Solid Tumor Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Solid Tumor Drug Market Report

Report Metric	Details
Report Name	Solid Tumor Drug Market
CAGR	5%
Segment by Type	Small Molecules Biologics
Segment by Application	Oncology Neurology Radiology Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca, Biogen, Baxter, Celgene Corporation, Abbott Laboratories, Pfizer Inc, Amgen Limited & Amgen Ireland Limited, Bristol-Myers Squibb Company, GlaxoSmithKline plc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Johnson & Johnson
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Solid Tumor Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Solid Tumor Drug Market report?

Ans: The main players in the Solid Tumor Drug Market are AstraZeneca, Biogen, Baxter, Celgene Corporation, Abbott Laboratories, Pfizer Inc, Amgen Limited & Amgen Ireland Limited, Bristol-Myers Squibb Company, GlaxoSmithKline plc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Johnson & Johnson

What are the Application segmentation covered in the Solid Tumor Drug Market report?

Ans: The Applications covered in the Solid Tumor Drug Market report are Oncology, Neurology, Radiology, Others

What are the Type segmentation covered in the Solid Tumor Drug Market report?

Ans: The Types covered in the Solid Tumor Drug Market report are Small Molecules, Biologics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Solid Tumor Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Small Molecules

1.2.3 Biologics

1.3 Market by Application

1.3.1 Global Solid Tumor Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Oncology

1.3.3 Neurology

1.3.4 Radiology

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Solid Tumor Drug Market Perspective (2020-2031)

2.2 Global Solid Tumor Drug Growth Trends by Region

2.2.1 Global Solid Tumor Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Solid Tumor Drug Historic Market Size by Region (2020-2025)

2.2.3 Solid Tumor Drug Forecasted Market Size by Region (2026-2031)

2.3 Solid Tumor Drug Market Dynamics

2.3.1 Solid Tumor Drug Industry Trends

2.3.2 Solid Tumor Drug Market Drivers

2.3.3 Solid Tumor Drug Market Challenges

2.3.4 Solid Tumor Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Solid Tumor Drug Players by Revenue

3.1.1 Global Top Solid Tumor Drug Players by Revenue (2020-2025)

3.1.2 Global Solid Tumor Drug Revenue Market Share by Players (2020-2025)

3.2 Global Solid Tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Solid Tumor Drug Revenue

3.4 Global Solid Tumor Drug Market Concentration Ratio

3.4.1 Global Solid Tumor Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Solid Tumor Drug Revenue in 2024

3.5 Global Key Players of Solid Tumor Drug Head office and Area Served

3.6 Global Key Players of Solid Tumor Drug, Product and Application

3.7 Global Key Players of Solid Tumor Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Solid Tumor Drug Breakdown Data by Type

4.1 Global Solid Tumor Drug Historic Market Size by Type (2020-2025)

4.2 Global Solid Tumor Drug Forecasted Market Size by Type (2026-2031)

5 Solid Tumor Drug Breakdown Data by Application

5.1 Global Solid Tumor Drug Historic Market Size by Application (2020-2025)

5.2 Global Solid Tumor Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Solid Tumor Drug Market Size (2020-2031)

6.2 North America Solid Tumor Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Solid Tumor Drug Market Size by Country (2020-2025)

6.4 North America Solid Tumor Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Solid Tumor Drug Market Size (2020-2031)

7.2 Europe Solid Tumor Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Solid Tumor Drug Market Size by Country (2020-2025)

7.4 Europe Solid Tumor Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Solid Tumor Drug Market Size (2020-2031)

8.2 Asia-Pacific Solid Tumor Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Solid Tumor Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Solid Tumor Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Solid Tumor Drug Market Size (2020-2031)

9.2 Latin America Solid Tumor Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Solid Tumor Drug Market Size by Country (2020-2025)

9.4 Latin America Solid Tumor Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Solid Tumor Drug Market Size (2020-2031)

10.2 Middle East & Africa Solid Tumor Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Solid Tumor Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Solid Tumor Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AstraZeneca

11.1.1 AstraZeneca Company Details

11.1.2 AstraZeneca Business Overview

11.1.3 AstraZeneca Solid Tumor Drug Introduction

11.1.4 AstraZeneca Revenue in Solid Tumor Drug Business (2020-2025)

11.1.5 AstraZeneca Recent Development

11.2 Biogen

11.2.1 Biogen Company Details

11.2.2 Biogen Business Overview

11.2.3 Biogen Solid Tumor Drug Introduction

11.2.4 Biogen Revenue in Solid Tumor Drug Business (2020-2025)

11.2.5 Biogen Recent Development

11.3 Baxter

11.3.1 Baxter Company Details

11.3.2 Baxter Business Overview

11.3.3 Baxter Solid Tumor Drug Introduction

11.3.4 Baxter Revenue in Solid Tumor Drug Business (2020-2025)

11.3.5 Baxter Recent Development

11.4 Celgene Corporation

11.4.1 Celgene Corporation Company Details

11.4.2 Celgene Corporation Business Overview

11.4.3 Celgene Corporation Solid Tumor Drug Introduction

11.4.4 Celgene Corporation Revenue in Solid Tumor Drug Business (2020-2025)

11.4.5 Celgene Corporation Recent Development

11.5 Abbott Laboratories

11.5.1 Abbott Laboratories Company Details

11.5.2 Abbott Laboratories Business Overview

11.5.3 Abbott Laboratories Solid Tumor Drug Introduction

11.5.4 Abbott Laboratories Revenue in Solid Tumor Drug Business (2020-2025)

11.5.5 Abbott Laboratories Recent Development

11.6 Pfizer Inc

11.6.1 Pfizer Inc Company Details

11.6.2 Pfizer Inc Business Overview

11.6.3 Pfizer Inc Solid Tumor Drug Introduction

11.6.4 Pfizer Inc Revenue in Solid Tumor Drug Business (2020-2025)

11.6.5 Pfizer Inc Recent Development

11.7 Amgen Limited & Amgen Ireland Limited

11.7.1 Amgen Limited & Amgen Ireland Limited Company Details

11.7.2 Amgen Limited & Amgen Ireland Limited Business Overview

11.7.3 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Introduction

11.7.4 Amgen Limited & Amgen Ireland Limited Revenue in Solid Tumor Drug Business (2020-2025)

11.7.5 Amgen Limited & Amgen Ireland Limited Recent Development

11.8 Bristol-Myers Squibb Company

11.8.1 Bristol-Myers Squibb Company Company Details

11.8.2 Bristol-Myers Squibb Company Business Overview

11.8.3 Bristol-Myers Squibb Company Solid Tumor Drug Introduction

11.8.4 Bristol-Myers Squibb Company Revenue in Solid Tumor Drug Business (2020-2025)

11.8.5 Bristol-Myers Squibb Company Recent Development

11.9 GlaxoSmithKline plc.

11.9.1 GlaxoSmithKline plc. Company Details

11.9.2 GlaxoSmithKline plc. Business Overview

11.9.3 GlaxoSmithKline plc. Solid Tumor Drug Introduction

11.9.4 GlaxoSmithKline plc. Revenue in Solid Tumor Drug Business (2020-2025)

11.9.5 GlaxoSmithKline plc. Recent Development

11.10 F. Hoffmann-La Roche Ltd.

11.10.1 F. Hoffmann-La Roche Ltd. Company Details

11.10.2 F. Hoffmann-La Roche Ltd. Business Overview

11.10.3 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Introduction

11.10.4 F. Hoffmann-La Roche Ltd. Revenue in Solid Tumor Drug Business (2020-2025)

11.10.5 F. Hoffmann-La Roche Ltd. Recent Development

11.11 Eli Lilly and Company

11.11.1 Eli Lilly and Company Company Details

11.11.2 Eli Lilly and Company Business Overview

11.11.3 Eli Lilly and Company Solid Tumor Drug Introduction

11.11.4 Eli Lilly and Company Revenue in Solid Tumor Drug Business (2020-2025)

11.11.5 Eli Lilly and Company Recent Development

11.12 Johnson & Johnson

11.12.1 Johnson & Johnson Company Details

11.12.2 Johnson & Johnson Business Overview

11.12.3 Johnson & Johnson Solid Tumor Drug Introduction

11.12.4 Johnson & Johnson Revenue in Solid Tumor Drug Business (2020-2025)

11.12.5 Johnson & Johnson Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Astrazeneca plc

Biogen

Baxter

Celgene Corporation

Abbott Laboratories

Pfizer Inc

Amgen Limited& Amgen Ireland Limited

Bristol Myers Squibb Company

GlaxoSmithKline PLC

F Hoffmann La Roche Ltd

Eli Lilly and Company

Johnson & Johnson

Amgen Limited& Amgen Ireland Limited

Johnson & Johnson

List of Tables

Table 1. Global Solid Tumor Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Small Molecules

Table 3. Key Players of Biologics

Table 4. Global Solid Tumor Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Solid Tumor Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Solid Tumor Drug Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Solid Tumor Drug Market Share by Region (2020-2025)

Table 8. Global Solid Tumor Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Solid Tumor Drug Market Share by Region (2026-2031)

Table 10. Solid Tumor Drug Market Trends

Table 11. Solid Tumor Drug Market Drivers

Table 12. Solid Tumor Drug Market Challenges

Table 13. Solid Tumor Drug Market Restraints

Table 14. Global Solid Tumor Drug Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Solid Tumor Drug Market Share by Players (2020-2025)

Table 16. Global Top Solid Tumor Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Tumor Drug as of 2024)

Table 17. Ranking of Global Top Solid Tumor Drug Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Solid Tumor Drug Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Solid Tumor Drug, Headquarters and Area Served

Table 20. Global Key Players of Solid Tumor Drug, Product and Application

Table 21. Global Key Players of Solid Tumor Drug, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Solid Tumor Drug Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Solid Tumor Drug Revenue Market Share by Type (2020-2025)

Table 25. Global Solid Tumor Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Solid Tumor Drug Revenue Market Share by Type (2026-2031)

Table 27. Global Solid Tumor Drug Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Solid Tumor Drug Revenue Market Share by Application (2020-2025)

Table 29. Global Solid Tumor Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Solid Tumor Drug Revenue Market Share by Application (2026-2031)

Table 31. North America Solid Tumor Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Solid Tumor Drug Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Solid Tumor Drug Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Solid Tumor Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Solid Tumor Drug Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Solid Tumor Drug Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Solid Tumor Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Solid Tumor Drug Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Solid Tumor Drug Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Solid Tumor Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Solid Tumor Drug Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Solid Tumor Drug Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Solid Tumor Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Solid Tumor Drug Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Solid Tumor Drug Market Size by Country (2026-2031) & (US$ Million)

Table 46. AstraZeneca Company Details

Table 47. AstraZeneca Business Overview

Table 48. AstraZeneca Solid Tumor Drug Product

Table 49. AstraZeneca Revenue in Solid Tumor Drug Business (2020-2025) & (US$ Million)

Table 50. AstraZeneca Recent Development

Table 51. Biogen Company Details

Table 52. Biogen Business Overview

Table 53. Biogen Solid Tumor Drug Product

Table 54. Biogen Revenue in Solid Tumor Drug Business (2020-2025) & (US$ Million)

Table 55. Biogen Recent Development

Table 56. Baxter Company Details

Table 57. Baxter Business Overview

Table 58. Baxter Solid Tumor Drug Product

Table 59. Baxter Revenue in Solid Tumor Drug Business (2020-2025) & (US$ Million)

Table 60. Baxter Recent Development

Table 61. Celgene Corporation Company Details

Table 62. Celgene Corporation Business Overview

Table 63. Celgene Corporation Solid Tumor Drug Product

Table 64. Celgene Corporation Revenue in Solid Tumor Drug Business (2020-2025) & (US$ Million)

Table 65. Celgene Corporation Recent Development

Table 66. Abbott Laboratories Company Details

Table 67. Abbott Laboratories Business Overview

Table 68. Abbott Laboratories Solid Tumor Drug Product

Table 69. Abbott Laboratories Revenue in Solid Tumor Drug Business (2020-2025) & (US$ Million)

Table 70. Abbott Laboratories Recent Development

Table 71. Pfizer Inc Company Details

Table 72. Pfizer Inc Business Overview

Table 73. Pfizer Inc Solid Tumor Drug Product

Table 74. Pfizer Inc Revenue in Solid Tumor Drug Business (2020-2025) & (US$ Million)

Table 75. Pfizer Inc Recent Development

Table 76. Amgen Limited & Amgen Ireland Limited Company Details

Table 77. Amgen Limited & Amgen Ireland Limited Business Overview

Table 78. Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Product

Table 79. Amgen Limited & Amgen Ireland Limited Revenue in Solid Tumor Drug Business (2020-2025) & (US$ Million)

Table 80. Amgen Limited & Amgen Ireland Limited Recent Development

Table 81. Bristol-Myers Squibb Company Company Details

Table 82. Bristol-Myers Squibb Company Business Overview

Table 83. Bristol-Myers Squibb Company Solid Tumor Drug Product

Table 84. Bristol-Myers Squibb Company Revenue in Solid Tumor Drug Business (2020-2025) & (US$ Million)

Table 85. Bristol-Myers Squibb Company Recent Development

Table 86. GlaxoSmithKline plc. Company Details

Table 87. GlaxoSmithKline plc. Business Overview

Table 88. GlaxoSmithKline plc. Solid Tumor Drug Product

Table 89. GlaxoSmithKline plc. Revenue in Solid Tumor Drug Business (2020-2025) & (US$ Million)

Table 90. GlaxoSmithKline plc. Recent Development

Table 91. F. Hoffmann-La Roche Ltd. Company Details

Table 92. F. Hoffmann-La Roche Ltd. Business Overview

Table 93. F. Hoffmann-La Roche Ltd. Solid Tumor Drug Product

Table 94. F. Hoffmann-La Roche Ltd. Revenue in Solid Tumor Drug Business (2020-2025) & (US$ Million)

Table 95. F. Hoffmann-La Roche Ltd. Recent Development

Table 96. Eli Lilly and Company Company Details

Table 97. Eli Lilly and Company Business Overview

Table 98. Eli Lilly and Company Solid Tumor Drug Product

Table 99. Eli Lilly and Company Revenue in Solid Tumor Drug Business (2020-2025) & (US$ Million)

Table 100. Eli Lilly and Company Recent Development

Table 101. Johnson & Johnson Company Details

Table 102. Johnson & Johnson Business Overview

Table 103. Johnson & Johnson Solid Tumor Drug Product

Table 104. Johnson & Johnson Revenue in Solid Tumor Drug Business (2020-2025) & (US$ Million)

Table 105. Johnson & Johnson Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. Solid Tumor Drug Picture

Figure 2. Global Solid Tumor Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Solid Tumor Drug Market Share by Type: 2024 VS 2031

Figure 4. Small Molecules Features

Figure 5. Biologics Features

Figure 6. Global Solid Tumor Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Solid Tumor Drug Market Share by Application: 2024 VS 2031

Figure 8. Oncology Case Studies

Figure 9. Neurology Case Studies

Figure 10. Radiology Case Studies

Figure 11. Others Case Studies

Figure 12. Solid Tumor Drug Report Years Considered

Figure 13. Global Solid Tumor Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Solid Tumor Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Solid Tumor Drug Market Share by Region: 2024 VS 2031

Figure 16. Global Solid Tumor Drug Market Share by Players in 2024

Figure 17. Global Top Solid Tumor Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Tumor Drug as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Solid Tumor Drug Revenue in 2024

Figure 19. North America Solid Tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Solid Tumor Drug Market Share by Country (2020-2031)

Figure 21. United States Solid Tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Solid Tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Solid Tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Solid Tumor Drug Market Share by Country (2020-2031)

Figure 25. Germany Solid Tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Solid Tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Solid Tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Solid Tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Solid Tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Solid Tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Solid Tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Solid Tumor Drug Market Share by Region (2020-2031)

Figure 33. China Solid Tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Solid Tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Solid Tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Solid Tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Solid Tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Solid Tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Solid Tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Solid Tumor Drug Market Share by Country (2020-2031)

Figure 41. Mexico Solid Tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Solid Tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Solid Tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Solid Tumor Drug Market Share by Country (2020-2031)

Figure 45. Turkey Solid Tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Solid Tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Solid Tumor Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. AstraZeneca Revenue Growth Rate in Solid Tumor Drug Business (2020-2025)

Figure 49. Biogen Revenue Growth Rate in Solid Tumor Drug Business (2020-2025)

Figure 50. Baxter Revenue Growth Rate in Solid Tumor Drug Business (2020-2025)

Figure 51. Celgene Corporation Revenue Growth Rate in Solid Tumor Drug Business (2020-2025)

Figure 52. Abbott Laboratories Revenue Growth Rate in Solid Tumor Drug Business (2020-2025)

Figure 53. Pfizer Inc Revenue Growth Rate in Solid Tumor Drug Business (2020-2025)

Figure 54. Amgen Limited & Amgen Ireland Limited Revenue Growth Rate in Solid Tumor Drug Business (2020-2025)

Figure 55. Bristol-Myers Squibb Company Revenue Growth Rate in Solid Tumor Drug Business (2020-2025)

Figure 56. GlaxoSmithKline plc. Revenue Growth Rate in Solid Tumor Drug Business (2020-2025)

Figure 57. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Solid Tumor Drug Business (2020-2025)

Figure 58. Eli Lilly and Company Revenue Growth Rate in Solid Tumor Drug Business (2020-2025)

Figure 59. Johnson & Johnson Revenue Growth Rate in Solid Tumor Drug Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Tumor Immunotherapy Market

Bulk Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Molecular Diagnosis of Tumors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oncology Anti cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prostate Cancer Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Generics Market

Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Testicular Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Cancer Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Generic Oncology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Brain Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

AI for Cancer Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non Small Cell Lung Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drugs for Non Small Cell Lung Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancers Immunotherapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Personalizing Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024

Prostate Cancer Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Breast Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions